Journal of the Canadian Association of Gastroenterology
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
A262 NEONATAL ACUTE LIVER FAILURE DUE TO PRESUMED GESTATIONAL ALLOIMMUNE LIVER DISEASE - A CASE REPORT
2023
-
A168 KAISO-INDUCED INTESTINAL INFLAMMATION IS ACCOMPANIED BY FAULTY CELL ADHESION AND ABERRANT INTESTINAL REPAIR.
2018
-
Role of serotonin-autophagy axis in regulation of epithelial cell function and microbiota composition in gut.
-
Canadian colorectal cancer screening programs: How do they measure up using the International Agency for Research on Cancer criteria for organized screening?.
7:312-318.
2024
-
The relationship among vedolizumab drug concentrations, biomarkers of inflammation, and clinical outcomes in a Canadian real-world study..
7:290-298.
2024
-
Inpatient Screening, Brief Intervention, and Referral to Treatment for Alcohol Use Disorder in Patients Admitted with Alcohol-associated Liver Disease Is Not Universally Implemented in Practice, But Can Reduce Readmissions for Alcohol-associated Hepatitis.
7:169-176.
2024
-
Measuring the Impact of Patient Engagement in Health Research: An Exploratory Study Using Multiple Survey Tools.
7:177-187.
2024
-
The Canadian Association of Gastroenterology’s New Climate Change Committee.
7:135-136.
2024
-
A113 COVID-19 VACCINATIONS IN IBD PATIENTS: PATIENT KNOWLEDGE AND PERCEPTIONS.
7:85-85.
2024
-
A13 MICROBIOTA FROM PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) INDUCE ALTERED BEHAVIOUR AND VISCERAL HYPERSENSITIVITY IN MICROBIOTA-HUMANIZED MICE.
7:7-7.
2024
-
A176 RESTORATION OF IMPAIRED MICROBIOTA-MEDIATED ARYL HYDROCARBON RECEPTOR SIGNALING IN PATIENTS WITH CELIAC DISEASE BY ORAL TRYPTOPHAN SUPPLEMENTATION: AN EXPLORATORY STUDY.
7:138-139.
2024
-
A187 PROPHYLACTIC PHAGE TREATMENT ENHANCES SUB-THERAPEUTIC EFFICACY OF BUDESONIDE AGAINST E. COLI DRIVEN COLITIS IN MICE COLONIZED WITH A DEFINED MICROBIOTA.
7:147-148.
2024
-
A189 INVESTIGATING THE ROLE OF BACTERIAL HISTAMINE METABOLISM IN VISCERAL HYPERALGESIA.
7:148-149.
2024
-
A19 THE IMPACT OF FOOD INSECURITY ON ADHERENCE TO A GLUTEN-FREE DIET IN THE ADULT CELIAC DISEASE POPULATION ATTENDING A DEDICATED CELIAC CLINIC.
7:10-11.
2024
-
A200 EXPOSURE TO CANNABIS SMOKE IN UTERO AFFECTS THE DEVELOPMENT OF THE ENDOCANNABINOID SYSTEM IN THE GASTROINTESTINAL TRACT.
7:157-158.
2024
-
A22 INVESTIGATING THE EFFECTS OF DIET TRIGGER DISCLOSURE ON BEHAVIOUR IN IRRITABLE BOWEL SYNDROME (IBS) PATIENTS WITH PERCEIVED GLUTEN SENSITIVITY.
7:12-13.
2024
-
A246 EXAMINING BARRIERS TO PHYSICAL ACTIVITY IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS.
7:198-198.
2024
-
A265 BARRIERS TO DIETARY MODIFICATION IN INFLAMMATORY BOWEL DISEASE (IBD): A MIXED-METHODS ASSESSMENT OF PATIENT PERCEPTIONS.
7:213-214.
2024
-
A303 SAFETY AND EFFICACY OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH LIVER CIRRHOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS.
7:246-247.
2024
-
A312 FACTORS ASSOCIATED WITH PHYSICAL SYMPTOM BURDEN AMONG PATIENTS WITH PANCREATIC CANCER.
7:254-254.
2024
-
A36 EFFECT OF FIBRE SUPPLEMENTATION IN CELIAC DISEASE: IMPLICATIONS FOR MUCOSAL HEALING.
7:20-21.
2024
-
A41 IDENTIFICATION OF MICROBIAL LYSOPHOSPHATIDYLCHOLINE (LPC) AND LYSOPHOSPHATIDIC ACID (LPA) PRODUCERS AND THEIR EFFECTS ON THE HOST.
7:24-25.
2024
-
A42 A HIGH SALT DIET INCREASES ELASTOLYTIC ACTIVITY AND WORSENS COLITIS IN GNOTOBIOTIC MICE.
7:25-25.
2024
-
A6 LYSOPHOSPHATIDYLCHOLINE (LPC) AND LYSOPHOSPHATIDIC ACID (LPA) INDUCE VISCERAL HYPERSENSITIVITY IN IRRITABLE BOWEL SYNDROME (IBS).
7:3-4.
2024
-
A63 RESTRAINED STRESS IN MICE INDUCES TRANSLOCATION OF GUT COMMENSAL BACTERIAL INTO DISTAL ORGANS.
7:42-43.
2024
-
A73 EVALUATING MENTAL HEALTH CONDITIONS IN YOUTH WITH INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE STUDY.
7:50-50.
2024
-
Emerging Roles of Gut Serotonin in Regulation of Immune Response, Microbiota Composition and Intestinal Inflammation.
7:88-96.
2024
-
A312 FACTORS ASSOCIATED WITH PHYSICAL SYMPTOM BURDEN AMONG PATIENTS WITH PANCREATIC CANCER.
7:254-254.
2024
-
Understanding Predictors of Crohn's Disease: Determinants of Altered Barrier Function in Pre-Disease Phase of Crohn's Disease.
7:68-77.
2024
-
Review and Critical Appraisal of Clinical Practice Guidelines of Modalities Used in the Diagnosis of Celiac Disease.
6:106-114.
2023
-
A13 THE RATE OF ADVERSE EVENTS AFTER COVID-19 VACCINATION IS SIMILAR IN PATIENTS WITH CELIAC DISEASE AND NON-CELIAC POPULATION: RESULTS OF A LARGE INTERNATIONAL CROSS-SECTIONAL STUDY.
6:7-8.
2023
-
A19 INVESTIGATING MECHANISMS THAT DRIVE SYMPTOMS IN IRRITABLE BOWEL SYNDROME PATIENTS WITH PERCEIVED GLUTEN SENSITIVITY.
6:10-11.
2023
-
A265 TEMPORAL DYNAMICS OF SYMPTOMS AND GUT MICROBIOTA IN EPISODES OF IRRITABLE BOWEL SYNDROME.
6:83-83.
2023
-
A266 DIET-BASED THERAPIES FOR INTESTINAL DYSFUNCTION INDUCED BY CLOSTRIDIOIDES DIFFICILE INFECTION.
6:83-84.
2023
-
A267 IDENTIFYING ENTEROBACTERIACEAE VIRULENCE GENES ASSOCIATED WITH ACTIVE DISEASE IN ULCERATIVE COLITIS PATIENTS USING CULTURE-DEPENDENT AND -INDEPENDENT APPROACHES.
6:84-85.
2023
-
A276 CANNABINOID RECEPTOR 1 IS LOCALIZED IN ENTERIC NEURONS AND EPITHELIUM IN FETAL AND EARLY POSTNATAL MOUSE INTESTINE.
6:90-90.
2023
-
A3 CROHN’S DISEASE PROTEOLYTIC MICROBIOTA ENHANCES INFLAMMATION THROUGH PAR2 PATHWAY IN GNOTOBIOTIC MICE.
6:2-2.
2023
-
A32 PHAGE TREATMENT DELAYS ONSET OF CROHN’S-ASSOCIATED E. COLI DRIVEN COLITIS IN MICE COLONIZED WITH A DEFINED MICROBIOTA.
6:17-18.
2023
-
A33 EFFECTS OF THE NEXT GENERATION PROBIOTIC, AKKERMANSIA MUCINIPHILA, ON INTESTINAL INFLAMMATION AND BARRIER FUNCTION.
6:18-18.
2023
-
A45 FIBER-FREE DIET REDUCES BACTEROIDES ABUNDANCE AND PREVENTS MUCUS DEGRADATION IN MICE COLONIZED WITH MICROBIOTA FROM PATIENTS WITH GENERALIZED ANXIETY DISORDER.
6:25-26.
2023
-
A53 FECAL BIOACTIVE PHOSPHOLIPIDS AS TRIGGERS OF INTESTINAL HYPERSENSITIVITY IN IRRITABLE BOWEL SYNDROME.
6:29-30.
2023
-
A56 DEVELOPMENT OF A PROGNOSTIC SURVIVAL MODEL FOR PATIENTS DIAGNOSED WITH PANCREATIC CANCER IN ONTARIO.
6:31-31.
2023
-
A62 IDENTIFICATION OF SPECIFIC COLONIC DEEP MUSCLE LAYER MACROPHAGES SUBSETS BY THE CD64 (FCΓRI) MARKER.
6:34-34.
2023
-
A7 OPPORTUNISTIC PATHOGEN MODULATION OF GLUTEN-REACTIVE CD4+ T CELL ACTIVATION BY DQ2-EXPRESSING ORGANOID MONOLAYERS.
6:4-4.
2023
-
A8 MICROBIAL ACTIVATION OF INTESTINAL DENDRITIC CELLS IS CRITICAL FOR THE ESTABLISHMENT OF NORMAL BEHAVIOR.
6:4-5.
2023
-
A87 PERSPECTIVES ON DIET MODIFICATION TO MANAGE THEIR SYMPTOMS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. A SCOPING REVIEW.
6:47-48.
2023
-
A262 NEONATAL ACUTE LIVER FAILURE DUE TO PRESUMED GESTATIONAL ALLOIMMUNE LIVER DISEASE - A CASE REPORT.
6:81-82.
2023
-
A56 DEVELOPMENT OF A PROGNOSTIC SURVIVAL MODEL FOR PATIENTS DIAGNOSED WITH PANCREATIC CANCER IN ONTARIO.
6:31-31.
2023
-
Efficacy of Intravenous Ustekinumab Reinduction in Patients With Crohn’s Disease With a Loss of Response.
5:208-213.
2022
-
Canadian Consensus Statements on the Transition of Adolescents and Young Adults with Inflammatory Bowel Disease from Pediatric to Adult Care: A Collaborative Initiative Between the Canadian IBD Transition Network and Crohn’s and Colitis Canada.
5:105-115.
2022
-
American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice Guideline: Management of Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Periendoscopic Period.
5:100-101.
2022
-
Comparative Effectiveness of Lumen-Apposing Metal Stents and Plastic Stents for the Treatment of Pancreatic Walled-Off Necrosis: A Meta-analysis.
5:68-78.
2022
-
A10 EARLY LIFE SENSITIZATION TO GLUTEN INDUCES SUSTAINED IMMUNOPATHOLOGY IN DR3-DQ2 MICE.
5:11-13.
2022
-
A13 GUT MICROBIOTA MODULATES CGRP PRODUCTION BY DRG NEURONS IN FEMALE MICE.
5:15-17.
2022
-
A14 THE INTESTINAL MICROBIOTA CONTRIBUTES TO AGE-RELATED MEMORY DECLINE.
5:17-18.
2022
-
A144 CHRONIC DSS LEADS TO ALTERED EXPRESSION OF IRAK4/TPL2 PATHWAYS IN UC-COLONIZED MICE.
5:17-18.
2022
-
A191 PERSISTENT BENEFIT OF DIETITIAN-LED GLUTEN-FREE DIET EDUCATION AT CD DIAGNOSIS ON DIETARY ADHERENCE IN CHILDREN AND ADULTS WITH TYPE 1 DIABETES AND CELIAC DISEASE.
5:75-76.
2022
-
A192 CONSUMPTION OF FOOD LOWER IN TRYPTOPHAN IS ASSOCIATED WITH SIGNIFICANT ANXIETY IN PATIENTS WITH CELIAC DISEASE.
5:76-77.
2022
-
A194 THE ADDITION OF DEAMIDATED GLIADIN PEPTIDE TO TISSUE TRANSGLUTAMINASE ANTIBODIES DOES NOT INCREASE THE ODDS OF CELIAC DISEASE DIAGNOSIS IN AN IGA SUFFICIENT POPULATION.
5:79-80.
2022
-
A196 DIARRHEA AS A PRESENTING SYMPTOM OF RELAPSED GRANULOMATOSIS WITH POLYANGIITIS.
5:81-82.
2022
-
A200 CROHN’S-ASSOCIATED E. COLI WORSEN COLITIS SEVERITY IN MICE COLONIZED WITH DEFINED MICROBIOTA.
5:85-86.
2022
-
A229 GUT MICROBIOTA PROFILES, DIET AND SHORT-CHAIN FATTY ACIDS AS PREDICTORS OF GENERALIZED ANXIETY DISORDER.
5:120-121.
2022
-
A241 KIWIFRUIT AND KIWIFRUIT EXTRACTS FOR TREATMENT OF CONSTIPATION: A SYSTEMATIC REVIEW AND META-ANALYSIS.
5:133-134.
2022
-
A246 GASTROINTESTINAL ADVERSE EVENTS OF CANNABINOIDS IN PEDIATRIC POPULATIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS.
5:138-139.
2022
-
A248 THE ROLE OF DIETARY TRYPTOPHAN IN INDOLE AND KYNURENINE PRODUCTION AND IMMUNE MODULATION IN HEALTHY INDIVIDUALS.
5:141-142.
2022
-
A34 GLUTEN-FREE DIET IMPROVES DYSPEPTIC SYMPTOMS IN PATIENTS WITH TYPE 1 DIABETES IN WHOM CELIAC DISEASE WAS EXCLUDED.
5:40-41.
2022
-
A46 BIOGEOGRAPHIC VARIATION AND FUNCTIONAL PATHWAYS OF THE GUT MICROBIOTA IN CELIAC DISEASE.
5:53-54.
2022
-
A5 GLUTEN-SPECIFIC T CELL ACTIVATION BY MHC CLASS II EXPRESSING ORGANOID MONOLAYERS.
5:6-6.
2022
-
A51 ROLE OF GUT MICROBIOTA IN THE EPISODIC NATURE OF SYMPTOMS IN IRRITABLE BOWEL SYNDROME.
5:58-60.
2022
-
A6 MECHANISMS UNDERLYING GUT DYSFUNCTION FOLLOWING C. DIFFICILE INFECTION AND IMPLICATIONS FOR TREATMENT.
5:6-8.
2022
-
A66 THE IMPACT OF A MULTIDISCIPLINARY ADOLESCENT AND YOUNG ADULT (AYA) INFLAMMATORY BOWEL DISEASE (IBD) ON CLINIC NO SHOW RATES.
5:76-77.
2022
-
A68 THERAPEUTIC EFFECTS OF MEDICINAL CANNABINOIDS ON THE GASTROINTESTINAL SYSTEM IN PEDIATRIC PATIENTS: A SYSTEMATIC REVIEW.
5:78-79.
2022
-
A66 THE IMPACT OF A MULTIDISCIPLINARY ADOLESCENT AND YOUNG ADULT (AYA) INFLAMMATORY BOWEL DISEASE (IBD) ON CLINIC NO SHOW RATES.
5:76-77.
2022
-
Reduction in Anxiety and Depression Scores Associated with Improvement in Quality of Life in Patients with Inflammatory Bowel Disease.
5:12-17.
2022
-
Canadian Association of Gastroenterology (CAG) Position Statement on the Use of Hyoscine-n-butylbromide (Buscopan) During Gastrointestinal Endoscopy.
4:259-268.
2021
-
Fecal Microbiota Transplantation for the Treatment of Ulcerative Colitis: A Qualitative Assessment of Patient Perceptions and Experiences.
4:e120-e129.
2021
-
Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 & Inflammatory Bowel Disease in Canada: A Knowledge Translation Strategy.
4:S10-S19.
2021
-
Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive Summary.
4:S1-S9.
2021
-
Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Health Care Delivery During the Pandemic and the Future Model of Inflammatory Bowel Disease Care.
4:S61-S67.
2021
-
Clinical and Laboratory Characteristics Are Associated With Biologic Therapy Use in Pediatric Inflammatory Bowel Disease: A Retrospective Cohort Study.
4:e92-e100.
2021
-
Declining Use of Corticosteroids for Crohn’s Disease Has Implications for Study Recruitment: Results of a Pilot Randomized Controlled Trial.
4:214-221.
2021
-
Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)—Part 2: Inactivated Vaccines.
161:681-700.
2021
-
Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)—Part 1: Live Vaccines.
4:e59-e71.
2021
-
Role ofN-Acetylcysteine in the Treatment of Acute Nonacetaminophen, Nonalcoholic and Nonviral Hepatitis: A Meta-analysis.
4:125-130.
2021
-
Fecal Calprotectin, CRP and Leucocytes in IBD Patients: Comparison of Biomarkers With Biopsy Results.
4:84-90.
2021
-
A13 A HIGH SALT DIET SYNERGIZES WITH UC MICROBIOTA TO INDUCE A PROINFLAMMATORY IMMUNE TONE IN IMMUNOCOMPETENT GNOTOBIOTIC MICE.
4:15-16.
2021
-
A232 AUTONOMIC FUNCTION ANALYSIS VIA HEART RATE VARIABILITY ASSOCIATED WITH PROPULSIVE MOTOR PATTERNS OF THE HUMAN COLON.
4:280-282.
2021
-
A235 EFFECTS OF SACRAL PHOTOBIOMODULATION ON THE AUTONOMIC NERVOUS SYSTEM IN PATIENTS WITH COLONIC DYSMOTILITY.
4:284-285.
2021
-
A238 ABSENCE OF AGE-RELATED MEMORY DECLINE IN GERM-FREE MICE.
4:288-289.
2021
-
A29 NOVEL FECAL BIOMARKERS THAT PRECEDE CLINICAL DIAGNOSIS OF ULCERATIVE COLITIS.
4:268-269.
2021
-
A35 ASSOCIATIONS BETWEEN AUTONOMIC DYSFUNCTION, COLONIC DYSMOTILITY AND ABSENT DEFECATION REFLEXES IN PATIENTS WITH CHRONIC REFRACTORY CONSTIPATION.
4:276-278.
2021
-
A39 CULTURE-ENRICHED METAGENOMICS REVEALED MICROBIAL ENGRAFTMENT FOLLOWING FMT IN PATIENTS WITH ULCERATIVE COLITIS.
4:269-270.
2021
-
A4 THE CIRCADIAN TIMING OF INFLAMMATORY BOWEL DISEASE.
4:4-5.
2021
-
A47 SYNTHETIC HUMAN MILK OLIGOSACCHARIDES PREVENT EXPERIMENTAL NECROTIZING ENTEROCOLITIS VIA DIVERGENT TRANSCRIPTOMIC RESPONSES..
4:272-274.
2021
-
A51 ENTERIC PARASITE INFECTION-INDUCED ALTERATION OF THE GUT MICROBIOTA REGULATES INTESTINAL GOBLET CELL BIOLOGY AND MUCIN PRODUCTION VIA TLR2 SIGNALING.
4:7-8.
2021
-
A8 DIETARY TRYPTOPHAN MODULATES KYNURENINE AND INDOLE PRODUCTION IN HEALTHY INDIVIDUALS.
4:9-10.
2021
-
A9 DORSAL ROOT GANGLIA NEURONAL RESPONSES AND SUBSTANCE P PRODUCTION ARE HIGHER IN MALE MICE.
4:10-11.
2021
-
A Cost-Utility Analysis of Switching from Reference to Biosimilar Infliximab Compared to Maintaining Reference Infliximab in Adult Patients with Crohn’s Disease.
4:48-48.
2021
-
COVID-19 Vaccination in Patients With Inflammatory Bowel Disease: Communiqué From the Canadian Association of Gastroenterology.
4:49-49.
2021
-
Clinical Management of the Microbiome in Irritable Bowel Syndrome.
4:36-43.
2021
-
Erratum.
4:50-50.
2021
-
The Defecation Reflex Assessed by High-Resolution Colonic Manometry.
4:1-2.
2021
-
An Electronic Clinical Decision-Making Tool for Patients with Suspected Colorectal Cancer—Preliminary Evaluation in Patients Presenting with Rectal Bleeding.
3:204-209.
2020
-
COVID-19: Framework for the Resumption of Endoscopic Activities From the Canadian Association of Gastroenterology.
3:243-245.
2020
-
Canadian Association of Gastroenterology Communique: After-Hours Endoscopy Cart.
3:222-227.
2020
-
Directly Mailing gFOBT Kits to Previous Responders Being Recalled for Colorectal Cancer Screening Increases Participation.
3:197-203.
2020
-
Propofol Use for Sedation in Endoscopic Procedures: Too Many Physicians in the Room?.
3:151-152.
2020
-
COVID-19: Advice from the Canadian Association of Gastroenterology for Endoscopy Facilities, as of March 16, 2020.
3:147-149.
2020
-
Response to Comments on the CAG/CCC Position Statement on Biosimilars for Inflammatory Bowel Disease.
3:98-99.
2020
-
The Gluten Free Diet: Assessing Adherence in a Pediatric Celiac Disease Population.
3:67-73.
2020
-
Ulcerative Colitis Patients Continue to Improve Over the First Six Months of Vedolizumab Treatment: 12-Month Clinical and Mucosal Healing Effectiveness.
3:74-82.
2020
-
A103 PROBIOTIC FORMULATIONS DIFFERENTIALLY AFFECT DISEASE OUTCOME IN A MOUSE MODEL OF NECROTIZING ENTEROCOLITIS.
3:119-120.
2020
-
A108 PROBIOTICS FOR CELIAC DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS.
3:125-126.
2020
-
A11 MICROBIAL AND METABOLOMIC PROFILES IDENTIFY SUBSETS OF DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME.
3:13-15.
2020
-
A118 GUT MICROBIOTA TRANSPLANTATION FROM A PATIENT WITH SEVERE CONSTIPATION INDUCED CHANGES IN COLONIC FUNCTION AND STRUCTUR OF GNOTOBIOTIC MICE.
3:137-138.
2020
-
A120 INFLUENCE OF THE MICROBIOTA ON THE POSTNATAL DEVELOPMENT OF THE ENTERIC NERVOUS SYSTEM IS DEPENDENT ON MOUSE STRAIN.
3:140-141.
2020
-
A121 SILENCING ENTERIC SENSORY NEURONS ABOLISHES THE EXCITATORY EFFECT OF SERTRALINE ON VAGAL AFFERENTS.
3:141-142.
2020
-
A122 THE INFLUENCE OF SEX AND THE GUT MICROBIOTA ON VISCERAL PAIN SENSITIVITY IN MICE.
3:142-143.
2020
-
A131 MALNUTRITION FOLLOWING IMPLEMENTATION OF A STRICT LOW FODMAP DIET FOR IBS.
3:151-152.
2020
-
A173 RECOGNIZING RARE PRESENTATIONS OF POLYPOSIS SYNDROMES AND THEIR ASSOCIATED MALIGNANCIES IN PEDIATRIC PATIENTS.
3:38-39.
2020
-
A19 NOVEL HLA-DQ2 TRANSGENIC MICE DEVELOP GLUTEN-IMMUNOPATHOLOGY FOLLOWING GLUTEN SENSITIZATION.
3:22-23.
2020
-
A191 EFFICIENCY OF TAILORED ERADICATION REGIMEN BASED ON ANTIBIOTIC SUSCEPTIBILITY AND CYP2C19 GENOTYPE TESTING IN CHILDREN WITH REFRACTORY HELICOBACTER PYLORI INFECTION.
3:62-63.
2020
-
A193 GLUTEN-FREE DIET IMPROVES DYSPEPSIA-LIKE SYMPTOMS IN A PILOT STUDY OF PATIENTS WITH TYPE 1 DIABETES MELLITUS.
3:64-65.
2020
-
A194 PRESENCE OF CELIAC DISEASE IN PATIENTS WITH BARRETT’S ESOPHAGUS IS ASSOCIATED WITH FASTER DEVELOPMENT OF DYSPLASIA AND HIGHER RATES OF ESOPHAGEAL ADENOCARCINOMA.
3:65-66.
2020
-
A197 MEDICAL INTERVENTIONS IN EOSINOPHILIC ESOPHAGITIS (EOE): A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (RCTS).
3:70-71.
2020
-
A200 HUMANIZED CELIAC-PRONE EPITHELIUM IN VITRO EXPRESS MHC-II AND CO-STIMULATORY MOLECULES NECESSARY FOR GLUTEN PEPTIDE PRESENTATION.
3:73-74.
2020
-
A209 ROLE OF SEROTONIN-AUTOPHAGY AXIS IN REGULATION OF EPITHELIAL CELL FUNCTION AND MICROBIOTA COMPOSITION IN GUT.
3:81-82.
2020
-
A210
ADLERCREUTZIA IS DEPLETED IN UC PATIENTS, EVEN BEFORE CLINICAL DIAGNOSIS, AND INVERSELY CORRELATES WITH FECAL ELASTOLYTIC ACTIVITY.
3:82-83.
2020
-
A219 PROTECTIVE EFFECTS OF AKKERMANSIA MUCINIPHILA ON INTESTINAL BARRIER FUNCTION AND INFLAMMATION.
3:93-94.
2020
-
A22 ADVERSE EARLY LIFE EVENTS ARE COMMON IN PATIENTS WITH FUNCTIONAL AND ORGANIC GASTROINTESTINAL DISORDERS.
3:26-27.
2020
-
A226 CHILD AND PARENT PERCEPTIONS OF FAECAL MICROBIOTA TRANSPLANT (FMT): QUALITATIVE PERSPECTIVES FROM PARTICIPANTS IN A TRIAL OF FMT FOR PEDIATRIC ULCERATIVE COLITIS.
3:101-102.
2020
-
A227 RESULTS OF THE FIRST PAEDIATRIC RANDOMIZED-CONTROLLED PILOT STUDY OF FAECAL MICROBIOTA TRANSPLANT FOR ACTIVE ULCERATIVE COLITIS (PEDIFETCH TRIAL).
3:102-103.
2020
-
A23 NUTRITIONAL DEFICIENCIES ARE FREQUENT IN CELIAC PATIENTS ON A GLUTEN-FREE DIET, REGARDLESS OF THE DURATION AND COMPLIANCE OF THE DIET.
3:27-28.
2020
-
A242 EXERCISE AND PHYSICAL ACTIVITY IN PEDIATRIC INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND RECOMMENDATIONS.
3:119-120.
2020
-
A261 MICROBIOTA PROFILES OF PATIENTS WITH MENTAL DISODERS DIFFER FROM THOSE OF HEALTHY CONTROLS.
3:138-139.
2020
-
A35 MICROBIAL PROTEOLYTIC SIGNATURE IN ULCERATIVE COLITIS INDUCES AN INFLAMMATORY SIGNATURE IN MICROBIOTA-HUMANIZED MICE.
3:42-43.
2020
-
A42 MICROBIAL METABOLISM OF DIETARY TRYPTOPHAN ENHANCES ARYL HYDROCARBON RECEPTOR ACTIVATION: IMPLICATIONS FOR IBD.
3:50-51.
2020
-
A43 β-DEFENSINS AS MARKERS OF INTESTINAL DYSBIOSIS: THE NATURE OF CHANGES IN β-DEFENSINS IS DEPENDENT ON THE PROCESS UNDERLYING THE INDUCTION OF DYSBIOSIS.
3:51-52.
2020
-
A45 INFLAMMATION AND INTESTINAL PERMEABILITY IN PEDIATRIC SHORT BOWEL SYNDROME.
3:53-54.
2020
-
A48 COLITIS FAVORS THE EXPANSION OF BACTERIA THAT ACTIVATE PAR2 AMPLIFYING INFLAMMATORY RESPONSE.
3:56-58.
2020
-
A50 TRANSFER OF DEPRESSIVE-LIKE PHENOTYPE TO GNOTOBIOTIC MICE DEPENDS ON MICROBIAL FEATURES SPECIFIC TO INDIVIDUAL PATIENTS.
3:59-60.
2020
-
A53 SACCHAROMYCES BOULARDII CNCM I-745 IMPROVES ANXIETY-LIKE BEHAVIOR AND RESCUES DYSMOTILITY IN A HUMANIZED MOUSE MODEL OF IRRITABLE BOWEL SYNDROME WITH CO-MORBID ANXIETY.
3:62-63.
2020
-
A55 LACK OF EXPERIMENTAL REPRODUCIBILITY IN PRECLINICAL RESEARCH IS INFLUENCED BY THE NUTRITIONAL PROFILE OF STANDARD RODENT CHOWS.
3:64-65.
2020
-
A11 MICROBIAL AND METABOLOMIC PROFILES IDENTIFY SUBSETS OF DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME.
3:13-15.
2020
-
A118 GUT MICROBIOTA TRANSPLANTATION FROM A PATIENT WITH SEVERE CONSTIPATION INDUCED CHANGES IN COLONIC FUNCTION AND STRUCTUR OF GNOTOBIOTIC MICE.
3:137-138.
2020
-
A122 THE INFLUENCE OF SEX AND THE GUT MICROBIOTA ON VISCERAL PAIN SENSITIVITY IN MICE.
3:142-143.
2020
-
A173 RECOGNIZING RARE PRESENTATIONS OF POLYPOSIS SYNDROMES AND THEIR ASSOCIATED MALIGNANCIES IN PEDIATRIC PATIENTS.
3:38-39.
2020
-
A191 EFFICIENCY OF TAILORED ERADICATION REGIMEN BASED ON ANTIBIOTIC SUSCEPTIBILITY AND CYP2C19 GENOTYPE TESTING IN CHILDREN WITH REFRACTORY HELICOBACTER PYLORI INFECTION.
3:62-63.
2020
-
A226 CHILD AND PARENT PERCEPTIONS OF FAECAL MICROBIOTA TRANSPLANT (FMT): QUALITATIVE PERSPECTIVES FROM PARTICIPANTS IN A TRIAL OF FMT FOR PEDIATRIC ULCERATIVE COLITIS.
3:101-102.
2020
-
A227 RESULTS OF THE FIRST PAEDIATRIC RANDOMIZED-CONTROLLED PILOT STUDY OF FAECAL MICROBIOTA TRANSPLANT FOR ACTIVE ULCERATIVE COLITIS (PEDIFETCH TRIAL).
3:102-103.
2020
-
A242 EXERCISE AND PHYSICAL ACTIVITY IN PEDIATRIC INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND RECOMMENDATIONS.
3:119-120.
2020
-
A261 MICROBIOTA PROFILES OF PATIENTS WITH MENTAL DISODERS DIFFER FROM THOSE OF HEALTHY CONTROLS.
3:138-139.
2020
-
A43 β-DEFENSINS AS MARKERS OF INTESTINAL DYSBIOSIS: THE NATURE OF CHANGES IN β-DEFENSINS IS DEPENDENT ON THE PROCESS UNDERLYING THE INDUCTION OF DYSBIOSIS.
3:51-52.
2020
-
A50 TRANSFER OF DEPRESSIVE-LIKE PHENOTYPE TO GNOTOBIOTIC MICE DEPENDS ON MICROBIAL FEATURES SPECIFIC TO INDIVIDUAL PATIENTS.
3:59-60.
2020
-
A53 SACCHAROMYCES BOULARDII CNCM I-745 IMPROVES ANXIETY-LIKE BEHAVIOR AND RESCUES DYSMOTILITY IN A HUMANIZED MOUSE MODEL OF IRRITABLE BOWEL SYNDROME WITH CO-MORBID ANXIETY.
3:62-63.
2020
-
A55 LACK OF EXPERIMENTAL REPRODUCIBILITY IN PRECLINICAL RESEARCH IS INFLUENCED BY THE NUTRITIONAL PROFILE OF STANDARD RODENT CHOWS.
3:64-65.
2020
-
Canadian Association of Gastroenterology Clinical Practice Guideline on the Management of Bile Acid Diarrhea.
3:e10-e27.
2020
-
Development of a Global Rating Scale for Inflammatory Bowel Disease.
3:4-16.
2020
-
Joint Canadian Association of Gastroenterology and Crohn’s Colitis Canada Position Statement on Biosimilars for the Treatment of Inflammatory Bowel Disease.
3:e1-e9.
2020
-
Anxiety, Depression and Quality of Life Improve After One Month and Three Months of Home Parenteral Nutrition: A Pilot Study in a Canadian Population.
2:178-185.
2019
-
Vaccination Guidelines for Patients with Immune-Mediated Disorders on Immunosuppressive Therapies—Executive Summary.
2:149-152.
2019
-
An Actively Bleeding Lesion in Video Capsule Endoscopy Study as a Source of Occult Gastrointestinal Bleeding.
2:99-100.
2019
-
Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn’s Disease.
2:e1-e34.
2019
-
Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn’s Disease.
2:e35-e63.
2019
-
Characterization of Serotonin Signaling Components in Patients with Inflammatory Bowel Disease.
2:132-140.
2019
-
The Benefit of Fentanyl in Effective Sedation and Quality of Upper Endoscopy: A Double-Blinded Randomized Trial of Fentanyl Added to Midazolam Versus Midazolam Alone for Sedation.
2:86-90.
2019
-
A136 A LONGITUDINAL STUDY EXAMINING FODMAP INTAKE AND THE METABOLOME IN IBS PATIENTS.
2:271-272.
2019
-
A139 A LOW FODMAP DIET REDUCES SYMPTOMS IN INDIVIDUAL IBS PATIENTS BUT NOT MUCOSAL IMMUNE ACTIVATION OF NOCICEPTORS.
2:277-278.
2019
-
A149 EARLY LIFE EVENTS IN PATIENTS WITH CELIAC DISEASE ARE COMMON AND ASSOCIATE WITH SEVERITY OF CONSTIPATION IN ADULTHOOD..
2:296-296.
2019
-
A152 D-LACTIC ACIDOSIS IN CHILDREN WITH SHORT BOWEL SYNDROME-A LITERATURE REVIEW AND REPORT OF TWO CASES.
2:301-302.
2019
-
A173 LACK OF EXPERIMENTAL REPRODUCIBILITY IN PRECLINICAL RESEARCH: FOCUS ON DIETARY CONTENT OF FERMENTABLE CARBOHYDRATE (FODMAPS) IN STANDARD RODENT CHOWS.
2:340-341.
2019
-
A241 APPLICATION OF NEXT GENERATION QUALITY AND EXPERT-LED CASE REVIEW TO INCREASE THE CONSISTENCY OF SESSILE SERRATED ADENOMA DIAGNOSTIC RATES: A CANADIAN TERTIARY-CARE CENTRE EXPERIENCE.
2:472-473.
2019
-
A32 THE ROLE OF GUT MICROBIOTA AND TRACE AMINES IN A MURINE MODEL OF GENERALIZED ANXIETY DISORDER.
2:64-65.
2019
-
A33 ROLE OF SEROTONIN-AUTOPHAGY AXIS IN INTESTINAL INFLAMMATION.
2:66-67.
2019
-
A38 DIETARY FODMAP CONTENT MODULATES FERMENTATION PATTERNS IN PRECLINICAL MODELS OF IBD BUT DOES NOT EXACERBATE OVERT INFLAMMATION.
2:76-77.
2019
-
A4 INVESTIGATING MICROBIAL ENGRAFTMENT VIA A COMPREHENSIVE CULTURE-ENRICHED AND CULTURE-INDEPENDENT METAGENOMICS IN PATIENTS WITH ULCERATIVE COLITIS.
2:9-10.
2019
-
A46 FECAL β-DEFENSIN LEVELS AS A RELIABLE BIOMARKER OF INTESTINAL DYSBIOSIS.
2:92-93.
2019
-
A48 NOVEL INTESTINAL ORGANOID-DERIVED MONOLAYERS TO MODEL CELIAC EPITHELIUM IN VITRO.
2:96-96.
2019
-
A49 LACTOBACILLI DEGRADE WHEAT AMYLASE TRYPSIN INHIBITORS (ATI) TO AMELIORATE GUT DYSFUNCTION INDUCED BY IMMUNOGENIC WHEAT PROTEINS.
2:97-98.
2019
-
A50 MICROBIOTA-MAST CELL INTERACTIONS IN A HUMANIZED MOUSE MODEL OF IBS.
2:99-100.
2019
-
A59 EXPLORING THE ROLE OF MICROBIOTA IN GASTROINTESTINAL MOTILITY.
2:118-119.
2019
-
A152 D-LACTIC ACIDOSIS IN CHILDREN WITH SHORT BOWEL SYNDROME-A LITERATURE REVIEW AND REPORT OF TWO CASES.
2:301-302.
2019
-
Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS).
2:6-29.
2019
-
Canadian Association of Gastroenterology Position Statement: Use of Cannabis in Gastroenterological and Hepatic Disorders.
2:37-43.
2019
-
Patient Engagement and Multidisciplinary Involvement Has an Impact on Clinical Guideline Development and Decisions: A Comparison of Two Irritable Bowel Syndrome Guidelines Using the Same Data.
2:30-36.
2019
-
Resident Survey on Gastroenterology Training in Canada.
2:44-48.
2019
-
Canadian Association of Gastroenterology Statement on the Putative Link
Between Proton Pump Inhibitor Treatment and Gastric Cancer after Helicobacter
pylori Eradication.
1:155-158.
2018
-
Clinical Practice Guideline for the Medical Management of Perianal
Fistulizing Crohn’s Disease: The Toronto Consensus.
1:141-154.
2018
-
Impact of Adalimumab Patient Support Program’s Care Coach Calls on Clinical
Outcomes in Patients with Crohn’s Disease in Canada: An Observational Retrospective Cohort
Study.
1:191-198.
2018
-
Rectal Indomethacin Prevents Moderate to Severe Post-ERCP Pancreatitis and Death and Should Be Used Before the Procedure: A Meta-Analysis of Aggregate Subgroup Data.
1:67-75.
2018
-
Clinical Practice Guidelines for the Assessment of Uninvestigated Esophageal Dysphagia.
1:5-19.
2018
-
Journal of the Canadian Association of Gastroenterology.
1:1-1.
2018
-
A115 ROLE OF GUT SEROTONIN IN ANTIMICROBIAL PEPTIDE PRODUCTION.
1:203-203.
2018
-
A118 EXPOSURE TO CROHN’S DISEASE-ASSOCIATED ADHERENT-INVASIVE E.COLI (AIEC) AT THE HEIGHT OF INFECTIOUS COLITIS IMPAIRS HOST-MEDIATED CLEARANCE OF AIEC.
1:208-208.
2018
-
A13 PROTEOLYTIC BACTERIA PROMOTE INNATE IMMUNE ACTIVATION AND GLUTEN-INDUCED PATHOLOGY IN MICE..
1:23-24.
2018
-
A153 MEASURING QUALITY OF LIFE AND DISEASE ACTIVITY IN PEDIATRIC PATIENTS RECEIVING INDUCTION THERAPY OF EXCLUSIVE ENTERAL NUTRITION OR CORTICOSTEROIDS FOR ACTIVE INFLAMMATORY BOWEL DISEASE.
1:264-265.
2018
-
A19 BACTERIAL PROTEASES INCREASE SENSITIVITY TO DIETARY ANTIGEN THROUGH PAR-2 SIGNALING.
1:31-32.
2018
-
A20 GUT MICROBIOTA-DIET INTERACTION ALTER INTESTINAL MAST CELL NUMBERS AND DISTRIBUTION IN THE HUMANIZED IBS MOUSE MODEL.
1:33-34.
2018
-
A21 FERMENTABLE CARBOHYDRATE-MICROBIOME INTERACTIONS IN A MOUSE MODEL OF IBS.
1:35-36.
2018
-
A235 EXPLORING PATIENT FACTORS FOR CANCELLED OR MISSED APPOINTMENTS TO AN URGENT GASTROENTEROLOGY OUTPATIENT CLINIC..
1:345-345.
2018
-
A236 UTILIZATION OF AN URGENT GASTROENTEROLOGY CLINIC FOR PATIENTS SEEN IN THE EMERGENCY ROOM OR URGENT CARE CENTRE.
1:346-346.
2018
-
A237 COLONOSCOPY PREPARATION OPTIMIZATION FOR INPATIENTS (COIN STUDY). A RANDOMIZED CONTROLLED TRIAL COMPARING 4L PEGLYTE TO REGULAR DOSE PICO SALAX AND SPLIT DOSE PICO SALAX FOR COLONOSCOPY BOWEL PREPARATION IN HOSPITALIZED PATIENTS..
1:347-347.
2018
-
A263 IBS-D MICROBIOTA INDUCES GUT-BRAIN DYSFUNCTION BY DISRUPTING INTESTINAL NEURAL AND IMMUNE PATHWAYS.
1:458-458.
2018
-
A266 AMYLASE TRYPSIN INHIBITORS FROM WHEAT EXACERBATE GLUTEN-INDUCED PATHOLOGY AND ALTER GUT MICROBIOTA IN MICE.
1:462-462.
2018
-
A274 GUT MICROBIOTA REGULATES INNATE EPITHELIAL RESPONSES AGAINST AN ENTERIC BACTERIAL PATHOGEN.
1:396-396.
2018
-
A276 CHARACTERIZING MICROBIOTA COMPOSITION AND FUNCTION THAT PRECEDE DEVELOPMENT OF CLINICALLY RELEVANT INFLAMMATION IN UC PATIENTS.
1:399-400.
2018
-
A278 ESCHERICHIA ABUNDANCE AND LOW FECAL BUTYRATE IN CHILDREN WITH INTESTINAL FAILURE.
1:402-403.
2018
-
A279 COLONIZATION WITH PROTEOLYTIC BACTERIA INDUCES LOW-GRADE INFLAMMATION AND BARRIER DYSFUNCTION IN MICE.
1:404-404.
2018
-
A281 EFFECT OF A GLUTEN FREE DIET ON SYMPTOMS IN IBS PATIENTS STRATIFIED BY ANTIGLIADIN ANTIBODIES.
1:488-488.
2018
-
A284 CHARACTERIZING SIMULTANEOUS PRESSURE WAVES IN THE HUMAN COLON BY HIGH-RESOLUTION MANOMETRY.
1:409-410.
2018
-
A287 REACTIVITY OF THE EXTRINSIC AUTONOMIC NERVOUS SYSTEM ASSOCIATED WITH HUMAN COLONIC MOTOR PATTERNS.
1:413-414.
2018
-
A288 ANAL SPHINCTER RELAXATION ASSOCIATED WITH THE DEFECATION REFLEX AND GAS EXPULSION, ASSESSED BY HIGH-RESOLUTION COLONIC MANOMETRY.
1:415-416.
2018
-
A288 DISTINCT ROLES IN INNATE HOST DEFENSE AND SUSCEPTIBILITY TO COLONIC INJURY IN MUC2 MUCIN DEFICIENT AND SUFFICIENT MICROBIOTA.
1:499-500.
2018
-
A291 INVESTIGATING THE ROLE OF ANTIBIOTICS AND ADHERENT-INVASIVE E. COLI
IN THE PATHOGENESIS OF CROHN’S DISEASE.
1:505-505.
2018
-
A293 SQUALAMINE INCREASES VAGAL AFFERENT FIRING FREQUENCY IN AGING MICE.
1:421-421.
2018
-
A294 NORADRENALINE INHIBITS PROPULSIVE MOTOR PATTERNS BUT NOT SEGMENTING HAUSTRAL PROGRESSION IN THE RABBIT 3-TAENIATED COLON.
1:422-423.
2018
-
A294 ROLE OF MACROPHAGE IN GUT MICROBIOTA-BRAIN SIGNALING.
1:510-510.
2018
-
A295 FUCOSE AVAILABILITY AND ITS UTILIZATION IMPACT IN VIVO
ENTERIC PATHOGEN VIRULENCE..
1:511-512.
2018
-
A296 A RHYTHMIC MOTOR PATTERN ASSOCIATED WITH HIGH AMPLITUDE PRESSURE WAVES IN HUMAN HIGH-RESOLUTION COLONIC MANOMETRY.
1:425-426.
2018
-
A297 FREQUENT ADVERSE CHILDHOOD EVENTS IN PATIENTS WITH IBS AND ORGANIC GASTROINTESTINAL DISORDERS.
1:427-427.
2018
-
A3 A SERPIN-PRODUCING BIFIDOBACTERIA IMPROVES GLUTEN PATHOLOGY IN MICE.
1:4-5.
2018
-
A300 DIET-MICROBIOTA INTERACTIONS UNDERLIE SYMPTOMS IN IBS.
1:521-522.
2018
-
A301 ANTIBIOTICS INCREASE VAGAL AFFERENT FIRING IN THE MOUSE JEJUNUM.
1:432-432.
2018
-
A301 GUT MICROBIOTA FROM A PATIENT WITH GENERALIZED ANXIETY DISORDER INDUCES ANXIETY-LIKE BEHAVIOUR AND ALTERED BRAIN CHEMISTRY IN GNOTOBIOTIC MICE.
1:523-524.
2018
-
A302 LUMINAL SHORT-CHAIN FATTY ACIDS RESTORE MOTILITY IN GERM-FREE MICE.
1:525-526.
2018
-
A303 SIMULTANEOUS PRESSURE WAVES ARE A KEY COMPONENT OF HUMAN COLON MOTOR FUNCTION ASSESSMENT, USING HIGH-RESOLUTION COLONIC MANOMETRY (HRCM).
1:527-528.
2018
-
A306 LACTOBACILLUS RHAMNOSUS
JB-1 AMELIORATES COLONIC AGE-RELATED DYSMOTILITY.
1:531-532.
2018
-
A307 EFFECT OF SLOW SYNAPTIC EXCITATION ON MYENTERIC INTRINSIC PRIMARY AFFERENT NEURON BKCA CHANNEL ACTIVITY.
1:533-533.
2018
-
A309 ANTIBIOTIC DRIVEN CHANGES IN GUT MOTILITY HIGHLIGHT DIRECT MODULATION OF ENTERIC NERVOUS SYSTEM.
1:536-536.
2018
-
A330 PREVENTION OF POST-ERCP PANCREATITIS: DO PROTEASE INHIBITORS HAVE A ROLE?.
1:475-476.
2018
-
A67 RAPID REDUCTION IN ANXIETY SCORES IN IBD PATIENTS AFTER INFLIXIMAB INFUSION IS ASSOCIATED WITH CHANGES IN KYNURENINE/TRYPTOPHAN METABOLISM.
1:106-106.
2018
-
A8 INFLUENCE OF MATERNAL SSRI EXPOSURE ON THE DEVELOPMENT OF THE ENTERIC NERVOUS SYSTEM.
1:12-12.
2018
-
A8 PROLONGED FASTING ALTERS THE GUT MICROBIOME AND PROTECTS AGAINST SALMONELLA
-INDUCED GUT INFLAMMATION.
1:14-15.
2018
-
A84 INTERACTION OF SEROTONIN WITH PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-GAMMA IN ANTIMICROBIAL PEPTIDE PRODUCTION IN GUT.
1:128-128.
2018
-
A153 MEASURING QUALITY OF LIFE AND DISEASE ACTIVITY IN PEDIATRIC PATIENTS RECEIVING INDUCTION THERAPY OF EXCLUSIVE ENTERAL NUTRITION OR CORTICOSTEROIDS FOR ACTIVE INFLAMMATORY BOWEL DISEASE.
1:264-265.
2018
-
Real-life management of chronic hepatitis C virus infection in Canada: Description of patient profile, prognostic factors and treatment strategies.
1:326-328.
2018
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)